Market revenue in 2023 | USD 296.6 million |
Market revenue in 2030 | USD 443.2 million |
Growth rate | 5.9% (CAGR from 2023 to 2030) |
Largest segment | Biologics |
Fastest growing segment | Biologics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications |
Key market players worldwide | ConvaTec Group PLC, 3M Co, Coloplast A/S ADR, Smith & Nephew PLC, Medtronic PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetic foot ulcer treatment market will help companies and investors design strategic landscapes.
Biologics was the largest segment with a revenue share of 36.48% in 2023. Horizon Databook has segmented the Germany diabetic foot ulcer treatment market based on wound care dressings, biologics, therapy devices, antibiotic medications covering the revenue growth of each sub-segment from 2018 to 2030.
The healthcare facilities in Germany are significantly more advanced than several other European countries, which is likely to boost the country’s market. For instance, as per the European Commission in 2017, around 84.5% of healthcare expenditure was publicly funded, and around 12.5% constituted out-of-pocket spending.
In addition, increasing prevalence of diabetes disorder is anticipated to drive the market. Germany has a lucrative environment for technologically innovative startups. Around 80% of the local medical device manufacturers, including companies offering wound dressing & negative pressure wound therapy devices, are SMEs.
The presence of major market players, such as B. Braun SE, Paul Hartmann AG, and URGO, is anticipated to create lucrative opportunities in Germany. Moreover, many companies are entering into strategic alliances, such as partnerships, mergers, agreements, and the launch of novel products.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany diabetic foot ulcer treatment market , including forecasts for subscribers. This country databook contains high-level insights into Germany diabetic foot ulcer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account